Delusions in Patients with Dementia with Lewy Bodies and the Associated Factors
Table 2
Two models of risk estimates (odds ratios) for cognitive domains in CASI between the delusional and nondelusional patients with DLB.
Features
Mean (SD, range)
Model 1
Model 2
Delusional
Nondelusional
OR (95% CI)
p
OR (95% CI)
p
N
106
101
Remote memory
6.6 (3.3, 0–10)
7.3 (3.2, 0–10)
0.95 (0.87–1.04)
NS
1.05 (0.94–1.17)
NS
Recent memory
4.2 (3.4, 0–12)
5.4 (3.7, 0–12)
0.92 (0.85–1.00)
NS
1.00 (0.90–1.10)
NS
Attention
5.2 (2.2, 0–8)
5.4 (2.2, 0–8)
0.98 (0.86–1.12)
NS
1.09 (0.94–1.27)
NS
Mental manipulation
2.5 (2.9, 0–10)
4.0 (3.5, 0–10)
0.86 (0.77–0.95)
0.002
0.91 (0.81–1.03)
NS
Orientation
6.7 (4.8, 0–18)
9.0 (6.0, 0–18)
0.93 (0.88–0.98)
0.008
0.99 (0.92–1.06)
NS
Abstract thinking
4.1 (2.8, 0–11)
4.8 (3.0, 0–12)
0.95 (0.85–1.05)
NS
1.04 (0.91–1.08)
NS
Language
6.8 (3.1, 0–10)
7.1 (3.0, 0–10)
0.98 (0.89–1.07)
NS
1.08 (0.96–1.20)
NS
Draw
4.8 (3.8, 0–10)
5.9 (3.9, 0–10)
0.94 (0.87–1.01)
NS
1.01 (0.92–1.10)
NS
Animal naming (verbal fluency)
4.0 (3.0, 0–10)
4.8 (3.3, 0–10)
0.94 (0.86–1.03)
NS
1.02 (0.92–1.14)
NS
DLB: dementia with Lewy bodies; CASI: Cognitive Abilities Screening Instrument; NS: not significant. The odds ratio (OR) and 95% confidence interval (CI) were calculated with the nondelusional group as reference. Model 1 ORs were adjusted for age, gender, and education; model 2 ORs were adjusted for age, gender, education, disease severity, antipsychotics, and antiparkinsonian agents.
